Nawsheen Chowdhury

Nawsheen Chowdhury practices at Long Island Jewish Valley Stream / Ekg/Echo - Electrocardiology - HOPD in Valleystream, New York.

Nawsheen Chowdhury's NPI, 1649661174, was assigned on February 5, 2015. Nawsheen Chowdhury holds New York license 287795.

Nawsheen Chowdhury's primary practice is Long Island Jewish Valley Stream / Ekg/Echo - Electrocardiology - HOPD, at 900 Franklin Ave, Valleystream, NY 11580.

Nawsheen Chowdhury's primary practice is Long Island Jewish Valley Stream / Ekg/Echo - Electrocardiology - HOPD in Valleystream, New York. Nawsheen Chowdhury is also affiliated with Long Island Jewish Medical Center. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Nawsheen Chowdhury to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Nawsheen Chowdhury practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Nawsheen Chowdhury's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Nawsheen Chowdhury is licensed in New York.

CMS data shows 594 Medicare services from Nawsheen Chowdhury across 4 procedure codes in 2024, for 187 Medicare patients. Medicare paid $46,592 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 187 Medicare patients who saw Nawsheen Chowdhury in 2024. The largest group is 75 to 84, with 71 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 52% are also on Medicaid. Their average risk score is 2.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Nawsheen Chowdhury's median patient age at 77, with 53% women.

In 2024, Nawsheen Chowdhury wrote 254 Medicare Part D claims for 99 patients. 82% of them were for generic drugs. CMS names the drug for 43 of them, across 3 drugs with 11 or more claims each, at $135 in total drug cost. In 2023, CMS named 67 claims across 5 drugs.

Nawsheen Chowdhury accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Nawsheen Chowdhury from 2 drug and device companies from 2023 to 2024. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $20.